TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer

Overview of attention for article published in Frontiers in immunology, September 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,803 followers.

TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung ... https://t.co/0A1vfvvxeO

13 Dec 2021

Reply Repost Favourite

New Research: TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer: Immunotherapy, a chemotherapy-free process, has emerged as a promising therapeutic strategy to prolong the… https://t.co

17 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.